Are nutritional supplements for senior pets worth it?

By Laura Gaylord, DVM, DACVIM (Nutrition)

Advances in veterinary care have extended both canine and feline lifespans, and over one-third of the dog and cat population is classified as "senior."¹ Dogs are often considered senior after seven years of age or perhaps when over 10-11 years with giant breeds reaching this sooner, closer to 7.5 years. Cats may be considered senior at 10-11 years or older, with some guidelines describing a "geriatric" stage in the last quartile of life.^2,3 Record lifespans exceeding 31 years for dogs and 38 years for cats have been reported.⁴

Pet food nutrition has not kept pace, however, and there is no regulatory or scientific consensus defining nutrition needs for a senior dog or cat. Feeding standards guiding commercial pet food formulation were built for growth and adult maintenance.² As a result, senior-marketed diets are formulated often with the same nutrient levels as an adult maintenance diet.³ Pet food companies define their own philosophies on senior nutrition as no consensus currently exists.

Aging genuinely changes physiology in both dogs and cats, though not identically in all individuals (Table 1). Older dogs and cats are prone to losing lean muscle mass even when appetite and body weight are normal, a pattern especially pronounced in cats which can lose lean tissue from middle age onward while body weight remains stable.^3,5 Both species retain body water less efficiently and have lessened thirst responses along with reduce renal sensitivity to arginine vasopressin (AVP) (also called antidiuretic hormone (ADH)) which reduces renal water reabsorption and increases dehydration risk. Fatty acid needs may shift, with an increased need for anti-inflammatory nutrients such as omega-3s.² Risk of joint disease, cognitive decline and chronic kidney also rise with age, the latter especially prevalent in senior and geriatric cats.^3,6 A standard adult, or "senior," maintenance diet will likely not address these changes, which is the gap targeted supplementation may attempt to fill.

Areas of interest for supplemental intervention in aging dogs and cats include cognitive function and brain aging, joint health and mobility and renal support, with joint health, mobility and muscle mass maintenance a related and growing area of interest. Published evidence for supplementation beyond optimizing diet remains extremely limited. This article presents current peer-reviewed evidence, noting where it may differ meaningfully between dogs and cats.

For cognitive function

Canine cognitive dysfunction syndrome affects 20–68 percent of senior dogs, depending on age and diagnostic criteria,³ while feline cognitive dysfunction affects roughly one-third of cats aged 11 to 14, rising further with age.⁷ Although multiple supplements are proposed for canine cognitive dysfunction (Table 2), a 2025 systematic review identified just 30 clinical trials testing enriched diets or nutraceuticals (27 in dogs, two in cats).⁷

Long-chain omega-3 fatty acids (eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) have the strongest, most consistent evidence of any nutrient reviewed, improving learning and cognition at higher doses in both species (approximately 26–67.5 mg/kg DHA and 27–43 mg/kg EPA).⁷ In cats, an enriched diet supplying EPA, DHA, vitamins E and C, B vitamins, and arginine improved learning, executive function, and visuospatial performance in middle-aged and older cats over a year-long trial.^7,8 DHA, abundant in brain tissue, is neuroprotective, enhances synaptic membrane fluidity, reduces pro-inflammatory metabolites, enhances antioxidant defenses, promotes neurogenesis, and increases glucose transporter activity.⁷ It also supports phosphatidylserine production which preserves brain signaling pathways.³

Medium-chain triglycerides (MCTs) at approximately 5.5-9 percent of the diet improved executive and visuospatial function in laboratory and pet dogs, likely by raising ketone bodies, an alternative fuel source for aging neurons (evidence limited to dogs).^3,7 S-adenosylmethionine (SAMe) may improve executive functions in both dogs and cats by stimulating brain glutathione production and reducing oxidative stress.⁹  Apoaequorin, a calcium-buffering protein, improved learning and executive functions in a short-term canine trial, and homotaurine, a GABA/taurine analog, improved learning and executive functions while preventing memory decline over a one-year canine study. Neither have been evaluated in cats.⁷ A placebo-controlled trial in aged beagles found that a nutraceutical combining phosphatidylserine, Ginkgo biloba, vitamin E, and pyridoxine improved short-term memory performance.¹⁰

Plant-derived antioxidants (polyphenols and vitamins E and C) used alone have been disappointing in dogs, possibly due to the "antioxidant paradox" in which high doses act as pro-oxidants.⁷ Antioxidants combined with mitochondrial cofactors acetyl-L-carnitine (ALCAR) and alpha-lipoic acid (LA) showed more consistent memory benefit. LA alone (2.7 mg/kg) and ALCAR (27.5 mg/kg) each tended to worsen learning, whereas their combination (2.7 mg/kg LA plus 5.4 mg/kg ALCAR) improved memory in two of three trials, showing that dose and combination matter as much as ingredient selection.⁷ This combination has not been tested in cats, in which alpha-lipoic acid is more toxic.⁷ Arginine (315–390 mg/kg), N-acetyl cysteine (NAC)(4–17 mg/kg), L-carnitine (2.7–4.7 mg/kg), and B vitamins consistently showed positive effects, but only in combination with other nutrients, while tryptophan consistently failed to demonstrate benefit in dogs. Small sample sizes, inconsistent cognitive assessment tools, and multi-ingredient formulations make single nutrient effects difficult to attribute.⁷ Long term studies are needed to establish efficacy and safety in both species.

For joint health, inflammation, and muscle maintenance

EPA and DHA have anti-inflammatory and anti-catabolic effects relevant to musculoskeletal aging in both species. Use will produce eicosanoids with lower inflammatory potency than those derived from omega-6 fatty acids, which can support muscle protein synthesis through activation of mTOR signaling, helping to counteract sarcopenia.³

Published canine dosing suggests combined EPA and DHA intakes of up to 310 mg × BW(kg)^0.75 for orthopedic disease, compared with 140 mg × BW(kg)^0.75 for renal and 115 mg × BW(kg)^0.75 for cardiovascular indications, so dosing should be condition specific. Feline dosing data is sparser, though EPA and DHA intakes of 200–300 mg combined per cat per day have been suggested.^3,11,12 Because polyunsaturated fatty acids oxidize readily, diet supplementation with antioxidants such as vitamin E is recommended whenever omega-3 are added.³

A 2022 meta-analysis pooling 72 trials of 38 nutraceuticals in osteoarthritic dogs and cats found meaningful analgesic benefit for omega-3-enriched diets and omega-3 supplements, the strongest evidence of any category reviewed.¹³ Multicenter placebo-controlled trials in osteoarthritic dogs showed improved weight-bearing and lower non-steroidal anti-inflammatory medication need (carprofen) with fish oil supplementation in a clear dose response relationship and lameness assessment.^14-17 A high omega-3 therapeutic diet produced comparable benefit in a separate canine trial.¹⁸ In cats, dietary long-chain omega-3 supplementation improved owner-assessed behavior and locomotion in cats with naturally occurring osteoarthritis¹⁹ similar to a high omega-3 therapeutic diet.¹¹

A supplement combining green-lipped mussel, curcumin, and blackcurrant leaf extract improved osteoarthritis scores along with grooming behaviors in cats more so than in dogs in a placebo-controlled crossover trial, though larger studies are needed.²⁰ A small 2026 accelerometry and machine learning trial evaluated a multi-ingredient joint supplement containing green-lipped mussels, salmon oil, vitamin C, blackcurrant extract, curcumin, glucosamine, chondroitin, and vitamin D3 in senior cats and found no consistent increase in overall activity but did find more stable activity patterns and increased grooming behavior, illustrating the measurement challenges of feline joint research.²¹ By contrast, the same 2022 meta-analysis found essentially no benefit for glucosamine-chondroitin sulfate combinations despite decades of use in veterinary practice and only weak support for collagen products. Undenatured type II collagen (UC-II) and eggshell membrane showed slight positive results in limited trials. Similar to other supplements, nutrients studied to support joint health should be evaluated individually as it can be difficult to assign benefits to any one active versus a combination.^2,13

Research on age-related muscle loss (sarcopenia) is limited in both species, a gap that matters more in cats, in which lean mass loss often begins in middle age and is masked by stable or rising fat mass.⁵ Feline sarcopenia and cachexia are thought to involve type II muscle fiber loss, mitochondrial dysfunction, reduced growth hormone and IGF-1 signaling, anabolic resistance to protein synthesis and low-grade inflammation. Anabolic resistance may indicate senior cats need more dietary protein, not less with aging. Muscle loss is a major component of frailty, which increases the risk of adverse outcomes.⁵ No pharmacological intervention or nutritional supplement has yet been researched or approved specifically for sarcopenic cats, though leucine, creatine, and ursolic acid are identified as promising candidates.⁵

In dogs recovering from tibial plateau leveling osteotomy, use of a fertilized egg yolk-derived myostatin inhibitor in recovery preserved thigh circumference and stable serum myostatin during activity restriction, while placebo-treated dogs lost muscle.²² However, this product was tested in post-surgical disuse-atrophy, not age-related sarcopenia. Maintaining adequate high-quality, bioavailable dietary protein remains the best-supported general strategy for preserving muscle in senior pets. Screening cats for lean-mass loss even when body weight looks stable is critical to early intervention.^3,5

Renal and metabolic considerations

Chronic kidney disease (CKD) prevalence rises with age in both species and has been estimated as high as 80.9 percent in cats over 15 years of age, making it arguably the single most important feline senior-nutrition concern.⁶ Highly bioavailable inorganic phosphorus, often used as palatant in cat foods and treats, has been implicated in dose-dependent kidney injury and renal disease progression when consumed in excess of dietary needs.^3,23-25 Because senior-labeled diets are not required to differ in phosphorus content, clinicians should review each products' guaranteed analysis.³ Notably, "All Life Stage" diets are formulated to meet AAFCO growth recommendations and will contain higher minerals, including phosphorus, which are unnecessary for senior pets.

For dogs with or at risk of CKD, omega-3 fatty acid supplementation at approximately 140 mg × BW (kg)^0.75 EPA + DHA is potentially beneficial. A 2025 double-blind, placebo-controlled trial in dogs with advanced CKD found that a once-daily multi-ingredient renal nutraceutical with chitosan, sodium bicarbonate, calcium carbonate, calcium lactate gluconate, Lactobacillus acidophilus D2/CSL, Olea europaea L. extract, and fructooligosaccharides given with a renal therapeutic diet reduced proteinuria, blood urea nitrogen and serum phosphorus with stable creatinine and symmetric dimethylarginine (SDMA) over the study period compared to diet alone,²⁶ although separating supplement from diet effects may be difficult. No equivalent supplement trial exists in cats, but one trial with 80 client-owned geriatric cats fed a diet enriched with fish oil, L-carnitine, and medium-chain triglycerides showed stable SDMA and creatinine over six months, while cats fed their owner-chosen diets showed progressive SDMA increases.^{27, 28} Hydration should be emphasized in both species with CKD given the age-related decline in thirst response.^2,3

Practical takeaways

The current evidence supports an individualized approach to senior supplementation rather than blanket use of any single product. Long-chain omega-3 fatty acids have the broadest, most consistent support across cognitive, joint, and anti-inflammatory outcomes in both species. Other nutraceuticals show targeted, species- and condition-specific benefits, particularly for cognition and CKD, while glucosamine-chondroitin lacks meaningful evidence. Supplementation for muscle loss remains the least studied area, especially in cats. Because currently there are no defined senior nutrient requirements, diet choice and supplementation should be tailored to each patient's body condition, organ function, cognition or musculoskeletal status rather than by product labeling. Larger, standardized, placebo-controlled trials are needed, especially in cats, where the evidence base lags behind dogs in every category reviewed.^2,3,5,13

Laura B. Gaylord, DVM, DACVIM (Nutrition), is an independent consultant and the owner/founder of Whole Pet Provisions, PLLC, a nutrition consulting company established in 2016, which offers veterinary nutrition consulting to pet owners, veterinarians, the pet food industry, and pet supplement companies. Dr. Gaylord offers homemade diet recipe formulation and commercial diet consultations through her business for pet parents and their veterinary teams.

References

1. Churchill, J.A.; Eirmann, L. Senior Pet Nutrition and Management. Clin. N. Am. Small Anim. Pract. 2021, 51, 635–651. https://doi.org/10.1016/j.cvsm.2021.01.004.
2. Cai, X., Mao, H., & Zhu, L. (2026). Nutrition research in aging dogs and cats: What we know and what we need to do. Animals, 16(4), 571. https://doi.org/10.3390/ani16040571
3. Stockman, J. (2024). Nutrition and aging in dogs and cats. In G. Wu (Ed.), Nutrition and metabolism of dogs and cats (Advances in Experimental Medicine and Biology, Vol. 1446, pp. 203–215). Springer. https://doi.org/10.1007/978-3-031-54192-6_9
4. Bermingham, E.N.; Patterson, K.A.; Shoveller, A.K.; Fraser, K.; Butowski, C.F.; Thomas, D.G. Nutritional needs and health outcomes of ageing cats and dogs: Is it time for updated nutrient guidelines? Anim. Front. 2024, 14, 5–16.
5. Chandler, M. (2026). Sarcopenia, cachexia and frailty in older cats: Mechanisms, assessment and therapeutic considerations. Journal of Feline Medicine and Surgery, 28(7). https://doi.org/10.1177/1098612X261426765
6. Marino, C. L., Lascelles, B. D. X., Vaden, S. L., Gruen, M. E., & Marks, S. L. (2014). Prevalence and classification of chronic kidney disease in cats randomly selected from four age groups and in cats recruited for degenerative joint disease studies. Journal of Feline Medicine and Surgery, 16(6), 465–472.
7. Blanchard, T., Eppe, J., Mugnier, A., Delfour, F., & Meynadier, A. (2025). Enhancing cognitive functions in aged dogs and cats: A systematic review of enriched diets and nutraceuticals. GeroScience, 47, 2925–2947. https://doi.org/10.1007/s11357-025-01521-z
8. Pan, Y., Araujo, J. A., Burrows, J., de Rivera, C., Gore, A., Bhatnagar, S., et al. (2013). Cognitive enhancement in middle-aged and old cats with dietary supplementation with a nutrient blend containing fish oil, B vitamins, antioxidants and arginine. British Journal of Nutrition, 110(1), 40–49.
9. Araujo, J. A., Faubert, M. L., Brooks, M. L., & Lobprise, H. (2012). NOVIFIT® (NoviSAMe®) tablets improve executive function in aged dogs and cats: Implications for treatment of cognitive dysfunction syndrome. International Journal of Applied Research in Veterinary Medicine, 10(2), 90–98.
10. Araujo JA, Landsberg GM, Milgram NW, Miolo A. "Improvement of short-term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, Ginkgo biloba, vitamin E, and pyridoxine." The Canadian Veterinary Journal. 2008;49(4):379-385. PMID: 18481547; free full text: PMC2275342.
11. Lascelles, B., DePuy, V., Thomson, A., et al. (2010). Evaluation of a therapeutic diet for feline degenerative joint disease. Journal of Veterinary Internal Medicine, 24(3), 487–495.
12. Parker, V. J. (2021). Nutritional management for dogs and cats with chronic kidney disease. Veterinary Clinics of North America: Small Animal Practice, 51(3), 685–710.
13. Barbeau-Grégoire, M., Otis, C., Cournoyer, A., Moreau, M., Lussier, B., & Troncy, E. (2022). A 2022 systematic review and meta-analysis of enriched therapeutic diets and nutraceuticals in canine and feline osteoarthritis. International Journal of Molecular Sciences, 23(18), 10384. https://doi.org/10.3390/ijms231810384
14. Fritsch, D. A., Allen, T. A., Dodd, C. E., Jewell, D. E., Sixby, K. A., Leventhal, P. S., Brejda, J., & Hahn, K. A. (2010a). A multicenter study of the effect of dietary supplementation with fish oil omega-3 fatty acids on carprofen dosage in dogs with osteoarthritis. Journal of the American Veterinary Medical Association, 236(5), 535–539. https://doi.org/10.2460/javma.236.5.535
15. Roush, J. K., Dodd, C. E., Fritsch, D. A., Allen, T. A., Jewell, D. E., Schoenherr, W. D., Richardson, D. C., Leventhal, P. S., & Hahn, K. A. (2010a). Multicenter veterinary practice assessment of the effects of omega-3 fatty acids on osteoarthritis in dogs. Journal of the American Veterinary Medical Association, 236(1), 59–66.
16. Roush, J. K., Cross, A. R., Renberg, W. C., Dodd, C. E., Sixby, K. A., Fritsch, D. A., Allen, T. A., Jewell, D. E., Richardson, D. C., Leventhal, P. S., & Hahn, K. A. (2010b). Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. Journal of the American Veterinary Medical Association, 236(1), 67–73.
17. Fritsch, D. A., Allen, T. A., Dodd, C. E., Jewell, D. E., Sixby, K. A., Leventhal, P. S., & Hahn, K. A. (2010b). Dose-titration effects of fish oil in osteoarthritic dogs. Journal of Veterinary Internal Medicine, 24(5), 1020–1026. https://doi.org/10.1111/j.1939-1676.2010.0572.x
18. Moreau, M., Troncy, E., Del Castillo, J. R. E., Bédard, C., Gauvin, D., & Lussier, B. (2013). Effects of feeding a high omega-3 fatty acids diet in dogs with naturally occurring osteoarthritis. Journal of Animal Physiology and Animal Nutrition, 97(5), 830–837. https://doi.org/10.1111/j.1439-0396.2012.01325.x
19. Corbee, R. J. (2013). The effect of dietary long-chain omega-3 fatty acid supplementation on owner's perception of behaviour and locomotion in cats with naturally occurring osteoarthritis. Journal of Animal Physiology and Animal Nutrition, 97. https://doi.org/10.1111/j.1439-0396.2012.01329.x
20. Corbee, R. J. (2022). The efficacy of a nutritional supplement containing green-lipped mussel, curcumin and blackcurrant leaf extract in dogs and cats with osteoarthritis. Veterinary Medicine and Science, 8(3), 1025–1035. https://doi.org/10.1002/vms3.779
21. Liu, Y., Smit, M., Andrews, C. J., Corner-Thomas, R. A., Draganova, I., & Thomas, D. G. (2026). Evaluating the efficacy of a joint supplement in senior cats using accelerometry and machine learning. Pets, 3(3), 40. https://doi.org/10.3390/pets3030040
22. White, D. A., Harkin, K. R., Roush, J. K., Renberg, W. C., & Biller, D. (2020). Fortetropin inhibits disuse muscle atrophy in dogs after tibial plateau leveling osteotomy. PLOS ONE, 15(4), e0231306. https://doi.org/10.1371/journal.pone.0231306
23. Coltherd, J. C., Staunton, R., Colyer, A., Thomas, G., Gilham, M., Logan, D. W., Butterwick, R., & Watson, P. (2019). Not all forms of dietary phosphorus are equal: An evaluation of postprandial phosphorus concentrations in the plasma of the cat. British Journal of Nutrition, 121(3), 270–284.
24. Coltherd, J. C., Alexander, J. E., Pink, C., et al. (2021). Towards establishing no observed adverse effect levels (NOAEL) for different sources of dietary phosphorus in feline adult diets: Results from a 7-month feeding trial. British Journal of Nutrition, 126(11), 1626–1641.
25. Coltherd, J. C., Staunton, R., Colyer, A., et al. (2022). Dietary calcium to phosphorus ratio affects postprandial phosphorus concentrations in feline plasma. British Journal of Nutrition, 128(9), 1689–1699.
26. Perondi, F., Ruggiero, A., Cutrignelli, M. I., Lippi, I., Meineri, G., & Martello, E. (2025). Efficacy of a once-daily supplement in managing canine chronic kidney disease. Animals, 15(19), 2884. https://doi.org/10.3390/ani15192884
27. Hall, J. A., Yerramilli, M., Obare, E., Yerramilli, M., Yu, S., & Jewell, D. E. (2014). Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in healthy geriatric cats fed reduced protein foods enriched with fish oil, L-carnitine, and medium-chain triglycerides. The Veterinary Journal, 202(3), 588–596.
28. Hall, J. A., MacLeay, J., Yerramilli, M., Obare, E., Yerramilli, M., Schiefelbein, H., Paetau-Robinson, I., & Jewell, D. E. (2016). Positive impact of nutritional interventions on serum symmetric dimethylarginine and creatinine concentrations in client-owned geriatric cats. PLOS ONE, 11(4), e0153654.